Industry:
Longevity
Location:
Netherlands
Role:
Seed Investor
Celljevity
Reversed ageing.
Celljevity is a next-gen longevity company combining regenerative biotech, AI diagnostics & advanced clinical protocols to restore youthful cellular function and extend human healthspan. Revefjes joined early as a seed investor.
As a recognized XPRIZE Healthspan Finalist, Celljevity is part of a global mission to extend healthy human life by a decade or two - or more.
Prometheus Technology
At the core of Celljevity lies the Prometheus Tech, a patented rejuvenation process that restores aged cells to a youthful state without genetic modification.
Over 1000 patients have undergone the protocol since 2018, with zero serious treatment-related adverse events reported.
Digital twin & European clinics
The biological process is complemented by Celljevity’s Digital Twin Platform. Using multi-omic data & AI modeling, each patient’s digital twin simulates different interventions to predict and optimize therapeutic outcomes. It’s personalized longevity.
Celljevity also operates longevity clinics in France and Dubai where medicine, data, and design converge. These clinics serve as living laboratories, turning the science of aging reversal into real, measurable experiences.
It has never been easier to live forever.
Espen Systad
Founder of Revefjes
